Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Flor Verghote
Profile
Projects
Publications
Activities
Awards & Distinctions
11
Results
2025
Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer : a phase 2 trial : results of secondary endpoints
Flor Verghote
Elke Rammant
Piet Dirix
Charles Van Praet
Charlien Berghen
Sara Junius
Nick Liefhooghe
Leen Noé
Piet Ost
Karel Decaestecker
et al.
A1
Journal Article
in
EUROPEAN UROLOGY FOCUS
2025
2024
Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)
Flor Verghote
Piet Dirix
Charles Van Praet
Charlien Berghen
Ben Vanneste
Sara Junius
Nick Liefhooghe
Leen Noé
Gert De Meerleer
Piet Ost
et al.
C3
Conference
2024
Can PET-CT improve the staging and outcome of patients with muscle-invasive bladder cancer?
Valerie Fonteyne
Flor Verghote
Camille Berquin
Daan De Maeseneer
Geert Villeirs
Kathia De Man
A2
Journal Article
in
AME CLINICAL TRIALS REVIEW
2024
Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice
Flor Verghote
Charles Van Praet
Camille Berquin
Nicolaas Lumen
Karel Decaestecker
Ben Vanneste
Elke Rammant
Valerie Fonteyne
A1
Journal Article
in
BMC CANCER
2024
2023
Indicaties voor radiotherapie bij blaaskanker met spierinvasie
Flor Verghote
Charles Van Praet
Daan De Maeseneer
Camille Berquin
Ben Vanneste
Pieter De Visschere
Sofie Verbeke
Valerie Fonteyne
A4
Journal Article
in
ONCO (NEDERLANDSE ED.)
2023
Radiotherapy use in muscle-invasive bladder cancer : review of the guidelines and impact of increased awareness in patient referral at a tertiary center in Belgium
Flor Verghote
Charles Van Praet
Daan De Maeseneer
Camille Berquin
Ben Vanneste
Pieter De Visschere
Sofie Verbeke
Valerie Fonteyne
A1
Journal Article
in
CANCER MANAGEMENT AND RESEARCH
2023
Role of radiotherapy as primary treatment for muscle-invasive bladder cancer : review of the guidelines and single-centre pattern of care analysis
Flor Verghote
Charles Van Praet
Daan De Maeseneer
Camille Berquin
Ben Vanneste
Pieter De Visschere
Sofie Verbeke
Valerie Fonteyne
C3
Conference
2023
2022
Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer : results of a multicentric phase II trial
Valerie Fonteyne
P. Dirix
Charles Van Praet
C. Berghen
M. Albersen
S. Junius
N. Liefhooghe
L. Noé
G. De Meerleer
Piet Ost
et al.
A1
Journal Article
in
EUROPEAN UROLOGY FOCUS
2022
International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy : update from an IBIS workgroup
Flor Verghote
Paul Sargos
John P. Christodouleas
Vedang Murthy
Brian C. Baumann
Piet Dirix
Charlien Berghen
Leen Paelinck
Tom Vercauteren
Valerie Fonteyne
A1
Journal Article
in
PRACTICAL RADIATION ONCOLOGY
2022
2021
Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : results of a phase 2 trial
Flor Verghote
P. Dirix
Charles Van Praet
C. Berghen
M. Albersen
S. Junius
N. Liefhooghe
M. Brosens
G. De Meerleer
Piet Ost
et al.
C3
Conference
2021
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial
Flor Verghote
Lindsay Poppe
Sofie Verbeke
Piet Dirix
Maarten Albersen
Gert De Meerleer
Charlien Berghen
Piet Ost
Geert Villeirs
Pieter De Visschere
et al.
A1
Journal Article
in
BMC CANCER
2021